Hexem Bio

Developer of stem cell-based therapies for aging and disease prevention

placeNew York City, New York, United States calendar_todayFounded 2024 language hexemb.io

Social engagement

Social engagement: 1.6K social following, 7 posts in the last 12 months — below the industry typical range.

Investor mix

5 investors on record; lead investors include Draper.

Investor typeCountShare
Venture capital480%
Private equity120%

Recent activity

17 Jun 2026
Event
BIO International Convention
27 May 2026
Milestone
regulatory
Coming soon